1691 related articles for article (PubMed ID: 15857280)
21. Antiinflammatory therapy for dry eye.
Pflugfelder SC
Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
[TBL] [Abstract][Full Text] [Related]
22. A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies.
Honkanen RA; Huang L; Rigas B
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065120
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
24. Why the eye becomes dry: a cornea and lacrimal gland feedback model.
Mathers WD
CLAO J; 2000 Jul; 26(3):159-65. PubMed ID: 10946988
[TBL] [Abstract][Full Text] [Related]
25. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
26. Alpha-lipoic acid restores tear production in an animal model of dry eye.
Andrade AS; Salomon TB; Behling CS; Mahl CD; Hackenhaar FS; Putti J; Benfato MS
Exp Eye Res; 2014 Mar; 120():1-9. PubMed ID: 24394592
[TBL] [Abstract][Full Text] [Related]
27. Denervation of the Lacrimal Gland Leads to Corneal Hypoalgesia in a Novel Rat Model of Aqueous Dry Eye Disease.
Aicher SA; Hermes SM; Hegarty DM
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6981-9. PubMed ID: 26513503
[TBL] [Abstract][Full Text] [Related]
28. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
29. Corneal sensitivity following lacrimal gland excision in the rat.
Meng ID; Barton ST; Mecum NE; Kurose M
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3347-54. PubMed ID: 26024120
[TBL] [Abstract][Full Text] [Related]
30. Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical Subtypes.
Huang W; Huang L; Li W; Saglam MS; Tourmouzis K; Goldstein SM; Master A; Honkanen R; Rigas B
J Ocul Pharmacol Ther; 2022; 38(1):102-113. PubMed ID: 34964663
[No Abstract] [Full Text] [Related]
31. Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model.
Zhu L; Shen J; Zhang C; Park CY; Kohanim S; Yew M; Parker JS; Chuck RS
Mol Vis; 2009; 15():250-8. PubMed ID: 19190733
[TBL] [Abstract][Full Text] [Related]
32. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
33. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye.
Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293
[TBL] [Abstract][Full Text] [Related]
34. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
[TBL] [Abstract][Full Text] [Related]
35. Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease.
Bucolo C; Fidilio A; Fresta CG; Lazzara F; Platania CBM; Cantarella G; Di Benedetto G; Burgaletto C; Bernardini R; Piazza C; Barabino S; Drago F
Front Pharmacol; 2019; 10():1240. PubMed ID: 31680988
[TBL] [Abstract][Full Text] [Related]
36. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
[TBL] [Abstract][Full Text] [Related]
37. Topical naltrexone increases aquaporin 5 production in the lacrimal gland and restores tear production in diabetic rats.
Diaz D; Sassani JP; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2024; 249():10175. PubMed ID: 38756167
[TBL] [Abstract][Full Text] [Related]
38. [Mechanisms of perioperative corneal abrasions: alterations in tear film proteome].
Zernii EY; Gancharova OS; Ishutina IE; Baksheeva VE; Golovastova MO; Kabanova EI; Savchenko MS; Serebryakova MV; Sotnikova LF; Zamyatnin AA; Philippov PP; Senin II
Biomed Khim; 2016 Nov; 62(6):683-690. PubMed ID: 28026813
[TBL] [Abstract][Full Text] [Related]
39. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent.
Ubels JL; Clousing DP; Van Haitsma TA; Hong BS; Stauffer P; Asgharian B; Meadows D
Curr Eye Res; 2004 Jun; 28(6):437-44. PubMed ID: 15512952
[TBL] [Abstract][Full Text] [Related]
40. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
Oh HN; Kim CE; Lee JH; Yang JW
Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
